Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2007
10/04/2007DE102006016285A1 Medicament used to reduce risk of e.g. heart disease and urinary tract disease, comprises 5-methyl-(6S)-tetrahydrofolate, estrogen and/or gestagene, vitamin B6 and/or vitamin B2 and auxiliary or carrier materials
10/04/2007DE102006014390A1 Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung Associates of xanthates with cyclodextrins and their use
10/04/2007CA2647423A1 Triazolone derivative
10/04/2007CA2647111A1 Anti-igf-1r human monoclonal antibody formulation
10/04/2007CA2646952A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007CA2646712A1 Novel method
10/04/2007CA2646701A1 C-met protein kinase inhibitors for the treatment of proliferative disorders
10/04/2007CA2646244A1 Tetracycline compounds and methods of treatment
10/04/2007CA2644445A1 Inorganic selenium for treatment of benign tumors
10/03/2007EP1840215A1 Method of inhibiting telomerase activity and inhibitor
10/03/2007EP1840135A1 Anti-alhpha 9 integrin antibody and the use thereof
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1840122A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
10/03/2007EP1839677A1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof
10/03/2007EP1839676A2 Erythropoietin derivates
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839669A1 Novel angiogensis inhibitor
10/03/2007EP1839664A1 Agent for regulating bone formation
10/03/2007EP1839662A1 Antitumor agent
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1838737A2 Binding proteins specific for human matriptase
10/03/2007EP1838736A2 Cripto binding molecules
10/03/2007EP1838734A2 Antibodies against antigen presenting cells and uses thereof
10/03/2007EP1838718A1 Pyrrolopyrazoles, potent kinase inhibitors
10/03/2007EP1838712A1 Pyrazolopyrimidine compounds as antitumor agents
10/03/2007EP1838708A2 Pyrrolodihydroisoquinolines as antiproliferative agents
10/03/2007EP1838700A2 Disubstituted ureas as kinase inhibitors
10/03/2007EP1838696A1 Novel cyanoguanidine compounds
10/03/2007EP1838675A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
10/03/2007EP1838667A2 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
10/03/2007EP1838350A2 Modulators of itch ubiquitinase activity
10/03/2007EP1838347A1 Pharmaceutical compositions for treating diseases associated with nf-kappab activity
10/03/2007EP1838342A2 Methods to bypass cd+4 cells in the induction of an immune response
10/03/2007EP1838330A1 Treatment of solid cancers
10/03/2007EP1838324A2 Novel farnesyl protein transferase inhibitors and their use to treat cancer
10/03/2007EP1838322A2 Use of purine derivatives as hsp90 protein inhibitors and for treatment of cancer
10/03/2007EP1838321A2 Cxcr4 antagonists for the treatment of hiv infection
10/03/2007EP1838320A2 Cxcr4 antagonists for the treatment of medical disorders
10/03/2007EP1838319A2 Pde5 inhibitor compositions and methods for immunotherapy
10/03/2007EP1838307A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers
10/03/2007EP1838305A1 Radiosensitizer formulations comprising nitrohistidine derivatives
10/03/2007EP1838283A2 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
10/03/2007EP1747777A4 Medicinal agent
10/03/2007EP1648906B1 Organosilicon compounds and their use
10/03/2007EP1529044B1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/03/2007EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy
10/03/2007EP1456180B1 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use
10/03/2007EP1436011B1 Dendrimers for use in targeted delivery
10/03/2007EP1418921B1 Anti-tumour 2-alkoxyestradiol sulfamates
10/03/2007EP1414828B1 Antitumoral analogs
10/03/2007EP1412383B9 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/03/2007EP1353672B1 Synthesis of 4-amino-thalidomide enantiomers
10/03/2007EP1337285B1 Implants with a phosphazene-containing coating
10/03/2007EP1267839B1 Microspheres for active embolization
10/03/2007EP1227840B1 Adjuvanted genetic vaccines
10/03/2007EP1135482B1 Cancer cell vaccine
10/03/2007EP1100942B1 Herpes virus vectors for dendritic cells
10/03/2007EP1044013B9 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
10/03/2007EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases
10/03/2007EP0497828B2 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
10/03/2007CN101048428A Methods of using death receptor ligands and CD20 antibodies
10/03/2007CN101048424A Methods of using death receptor ligands and CD20 antibodies
10/03/2007CN101048418A Pi3-kinase
10/03/2007CN101048406A Novel substituted imidazole derivatives
10/03/2007CN101048398A Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole
10/03/2007CN101048383A 促性腺激素释放激素受体拮抗剂 Gonadotropin-releasing hormone receptor antagonist
10/03/2007CN101048152A Use of an mTOR inhibitor in treatment of uterine leiomyoma
10/03/2007CN101045926A Human CLL1 gene and its coded protein and application
10/03/2007CN101045924A Prepn and application of recombinant staphylococcus aureus enterotoxin O
10/03/2007CN101045727A Inhibitors of tyrosine kinases
10/03/2007CN101045721A Preparation of porcelain vine element unsaturated sodium salt and its application
10/03/2007CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3
10/03/2007CN101045165A Hydroxypropyl beta-cyclodextrin clathrate of astaxanthin, and its preparing method
10/03/2007CN101045163A High molecular anticarcinogenic prodrug, its preparing method and use
10/03/2007CN101045161A Modulators of P-selectin glycoprotein ligand 1
10/03/2007CN101045160A Hydrophobic agent used for target treatment to tumor blood vessel, its preparing method and use
10/03/2007CN101045157A Method for preparing high activity, soluble, recombination human endothelial chalone injection
10/03/2007CN101045156A Special target medicine and its use
10/03/2007CN101045107A Method for extracting pseudo-purslane saponin, and its application in medical field
10/03/2007CN101045073A Method for preparing extractive of liuyueqing and its application
10/03/2007CN101045068A Method for preparing total aponins of sea cucumber and application in medical fields of said medicine
10/03/2007CN101045067A 纳米生物导弹 Nanobiotechnology missile
10/03/2007CN101045066A Temperature sensing matter used for preparing medicine to inhibiting tumor angiogenesis, and its use
10/03/2007CN101045059A Anticarcinogen composition carried with both nitrosourea type medicine and guanine analog
10/03/2007CN101045049A Mutamycine C multivesicular liposome and its preparing method
10/03/2007CN101045046A Use of Brazil hemoatoxy type compound for preparing antineoplastic
10/03/2007CN101045037A Cationic elaioplast and its adenovirus composition, its preparing method and use
10/03/2007CN101045036A Delayed-release injection containing nitrous carbamide type medicine and topographic enzyme inhibitor
10/03/2007CN101045035A Anticancer composite carried with tyrosine kinase inhibitor and phosphoinositide 3-kinase inhibitor
10/03/2007CN101045033A Ply-glycosyl modified acid-sensitive nanometer gel
10/03/2007CN101044910A Seaweed health-care food and its preparing method
10/03/2007CN100340668C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
10/03/2007CN100340575C Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
10/03/2007CN100340573C Heterocarpine, human GHRH-binding protein
10/03/2007CN100340572C Novel LHRH antagonist
10/03/2007CN100340570C Solasodine salt of organic acid, its preparation method and application in medicine
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340545C Tetralone derivatives as antitumor agents
1 ... 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 ... 2211